What is the current analyst consensus rating for H. B. Fuller Company, and what is the average 12-month price target?

H. B. Fuller Company (NYSE: FUL) has received a consensus 'Moderate Buy' rating from analysts, with an average 12-month price target of $66.40.

How did H. B. Fuller's Q2 performance compare to expectations, and what action did the company take regarding its full-year guidance?

H. B. Fuller recently reported strong Q2 results, surpassing both revenue and EPS estimates, and subsequently raised its full-year EPS guidance.

H. B. Fuller Company Given Consensus Rating of "Moderate Buy" by Analysts

Jun 26, 2026

H.B. Fuller received a "Moderate Buy" consensus with a $66.40 price target after beating Q2 revenue and EPS estimates. However, its planned £715 million acquisition of Advanced Medical Solutions faces criticism from an activist investor regarding execution risk.

MarketBeat

2026-01-15

H.B. Fuller Beats Estimates Despite Volume Decline

2026-03-25

H.B. Fuller Beats Estimates on Raw Material Cost Savings

2026-04-16

H.B. Fuller Raises Quarterly Dividend 4.3% to 24.5 Cents Per Share

2026-05-08

How H.B. Fuller’s Margin-Focused Reshaping Amid Sector Headwinds Will Impact H.B. Fuller (FUL) Investors

2026-05-09

H.B. Fuller to Build Aerospace Innovation Center in North Carolina